{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:32:10Z","timestamp":1782300730545,"version":"3.54.5"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-02054-y","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T13:03:11Z","timestamp":1726059791000},"page":"1973-1983","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of kidney failure in adults diagnosed with hereditary tubulopathies"],"prefix":"10.1093","volume":"37","author":[{"given":"Maureen","family":"Betton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Houillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Vargas-Poussou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6444-2911","authenticated-orcid":false,"given":"Marguerite","family":"Hureaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"issue":"7","key":"2054_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL et al (2016) Global prevalence of chronic kidney disease\u2014a systematic review and meta-analysis. PLoS ONE 11(7):e0158765. https:\/\/doi.org\/10.1371\/journal.pone.0158765","journal-title":"PLoS ONE"},{"issue":"2","key":"2054_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7861\/clinmed.cg.20.2","volume":"20","author":"A Forbes","year":"2020","unstructured":"Forbes A, Gallagher H (2020) Chronic kidney disease in adults: assessment and management. Clin Med (Lond) 20(2):128\u2013132. https:\/\/doi.org\/10.7861\/clinmed.cg.20.2","journal-title":"Clin Med (Lond)"},{"issue":"10075","key":"2054_CR3","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P (2017) Chronic kidney disease. Lancet 389(10075):1238\u20131252. https:\/\/doi.org\/10.1016\/S0140-6736(16)32064-5","journal-title":"Lancet"},{"issue":"4","key":"2054_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000436983","volume":"130","author":"DM Connaughton","year":"2015","unstructured":"Connaughton DM, Bukhari S, Conlon P et al (2015) The Irish kidney gene project-prevalence of family history in patients with kidney disease in Ireland. Nephron 130(4):293\u2013301. https:\/\/doi.org\/10.1159\/000436983","journal-title":"Nephron"},{"issue":"3","key":"2054_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneph.2015.205","volume":"12","author":"A Vivante","year":"2016","unstructured":"Vivante A, Hildebrandt F (2016) Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol 12(3):133\u2013146. https:\/\/doi.org\/10.1038\/nrneph.2015.205","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"2054_CR6","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1681\/ASN.2018040441","volume":"29","author":"E Cornec-Le Gall","year":"2018","unstructured":"Cornec-Le Gall E, Harris PC (2018) The underestimated burden of monogenic diseases in adult-onset ESRD. J Am Soc Nephrol 29(6):1583\u20131584. https:\/\/doi.org\/10.1681\/ASN.2018040441","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2054_CR7","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.kint.2019.08.027","volume":"96","author":"M Hureaux","year":"2019","unstructured":"Hureaux M, Ashton E, Dahan K et al (2019) High-throughput sequencing contributes to the diagnosis of tubulopathies and familial hypercalcemia hypocalciuria in adults. Kidney Int 96(6):1408\u20131416. https:\/\/doi.org\/10.1016\/j.kint.2019.08.027","journal-title":"Kidney Int"},{"issue":"6","key":"2054_CR8","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.kint.2017.06.013","volume":"92","author":"AJ Mallett","year":"2017","unstructured":"Mallett AJ, McCarthy HJ, Ho G et al (2017) Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders. Kidney Int 92(6):1493\u20131506. https:\/\/doi.org\/10.1016\/j.kint.2017.06.013","journal-title":"Kidney Int"},{"issue":"3 Suppl 3","key":"2054_CR9","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1053\/j.ajkd.2008.07.059","volume":"53","author":"WM McClellan","year":"2009","unstructured":"McClellan WM, Satko SG, Gladstone E, Krisher JO, Narva AS, Freedman BI (2009) Individuals with a family history of ESRD are a high-risk population for CKD: implications for targeted surveillance and intervention activities. Am J Kidney Dis 53(3 Suppl 3):S100-106. https:\/\/doi.org\/10.1053\/j.ajkd.2008.07.059","journal-title":"Am J Kidney Dis"},{"key":"2054_CR10","unstructured":"Renal superpanel - broad (Version 2.352). https:\/\/panelapp.genomicsengland.co.uk\/panels\/902\/. Accessed 11 Mar 2021."},{"issue":"1","key":"2054_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ki.2013.444","volume":"85","author":"A Levin","year":"2014","unstructured":"Levin A, Stevens PE (2014) Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85(1):49\u201361. https:\/\/doi.org\/10.1038\/ki.2013.444","journal-title":"Kidney Int"},{"issue":"5","key":"2054_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17(5):405\u2013423. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"2","key":"2054_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.kint.2018.02.027","volume":"94","author":"G Bullich","year":"2018","unstructured":"Bullich G, Domingo-Gallego A, Vargas I et al (2018) A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases. Kidney Int 94(2):363\u2013371. https:\/\/doi.org\/10.1016\/j.kint.2018.02.027","journal-title":"Kidney Int"},{"issue":"4","key":"2054_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/gim.2017.119","volume":"20","author":"AC Lionel","year":"2018","unstructured":"Lionel AC, Costain G, Monfared N et al (2018) Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet Med 20(4):435\u2013443. https:\/\/doi.org\/10.1038\/gim.2017.119","journal-title":"Genet Med"},{"key":"2054_CR15","unstructured":"Lieske JC, Milliner DS, Beara-Lasic L, Harris P, Cogal A, Abrash E. Dent Disease. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews\u00ae. University of Washington, Seattle; 1993. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK99494\/. Accessed 20 Aug 2020."},{"issue":"5","key":"2054_CR16","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.kint.2016.12.017","volume":"91","author":"V Palazzo","year":"2017","unstructured":"Palazzo V, Provenzano A, Becherucci F et al (2017) The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis. Kidney Int 91(5):1243\u20131255. https:\/\/doi.org\/10.1016\/j.kint.2016.12.017","journal-title":"Kidney Int"},{"issue":"6","key":"2054_CR17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/ndt\/gfy409","volume":"34","author":"SC Lopez-Garcia","year":"2019","unstructured":"Lopez-Garcia SC, Emma F, Walsh SB et al (2019) Treatment and long-term outcome in primary distal renal tubular acidosis. Nephrol Dial Transplant 34(6):981\u2013991. https:\/\/doi.org\/10.1093\/ndt\/gfy409","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2054_CR18","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1056\/NEJMoa1103864","volume":"365","author":"KP Schlingmann","year":"2011","unstructured":"Schlingmann KP, Kaufmann M, Weber S et al (2011) Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 365(5):410\u2013421. https:\/\/doi.org\/10.1056\/NEJMoa1103864","journal-title":"N Engl J Med"},{"issue":"4","key":"2054_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00467-017-3873-3","volume":"34","author":"CA Wagner","year":"2019","unstructured":"Wagner CA, Rubio-Aliaga I, Hernando N (2019) Renal phosphate handling and inherited disorders of phosphate reabsorption: an update. Pediatr Nephrol 34(4):549\u2013559. https:\/\/doi.org\/10.1007\/s00467-017-3873-3","journal-title":"Pediatr Nephrol"},{"key":"2054_CR20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802836","author":"Z Karim","year":"2008","unstructured":"Karim Z, G\u00e9rard B, Bakouh N et al (2008) NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa0802836","journal-title":"N Engl J Med"},{"issue":"5","key":"2054_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2215\/CJN.12841211","volume":"7","author":"A Godron","year":"2012","unstructured":"Godron A, Harambat J, Boccio V et al (2012) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations. CJASN 7(5):801\u2013809. https:\/\/doi.org\/10.2215\/CJN.12841211","journal-title":"CJASN"},{"issue":"1","key":"2054_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.kint.2016.09.046","volume":"91","author":"A Blanchard","year":"2017","unstructured":"Blanchard A, Bockenhauer D, Bolignano D et al (2017) Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int 91(1):24\u201333. https:\/\/doi.org\/10.1016\/j.kint.2016.09.046","journal-title":"Kidney Int"},{"issue":"2","key":"2054_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.rdc.2014.01.005","volume":"40","author":"SE Sattui","year":"2014","unstructured":"Sattui SE, Singh JA, Gaffo AL (2014) Comorbidities in patients with crystal diseases and hyperuricemia. Rheumatic Dis Clin N Am 40(2):251\u2013278. https:\/\/doi.org\/10.1016\/j.rdc.2014.01.005","journal-title":"Rheumatic Dis Clin N Am"},{"issue":"7","key":"2054_CR24","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1681\/ASN.2015050542","volume":"27","author":"K Br\u00fcck","year":"2016","unstructured":"Br\u00fcck K, Stel VS, Gambaro G et al (2016) CKD prevalence varies across the european general population. J Am Soc Nephrol 27(7):2135\u20132147. https:\/\/doi.org\/10.1681\/ASN.2015050542","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2054_CR25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/MNH.0b013e32836214b9","volume":"22","author":"MT Keddis","year":"2013","unstructured":"Keddis MT, Rule AD (2013) Nephrolithiasis and loss of kidney function. Curr Opin Nephrol Hypertens 22(4):390\u2013396. https:\/\/doi.org\/10.1097\/MNH.0b013e32836214b9","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"2054_CR26","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1152\/physrev.00008.2018","volume":"99","author":"J van der Wijst","year":"2019","unstructured":"van der Wijst J, Belge H, Bindels RJM, Devuyst O (2019) Learning physiology from inherited kidney disorders. Physiol Rev 99(3):1575\u20131653. https:\/\/doi.org\/10.1152\/physrev.00008.2018","journal-title":"Physiol Rev"},{"issue":"10","key":"2054_CR27","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s00467-016-3499-x","volume":"32","author":"Y van Berkel","year":"2017","unstructured":"van Berkel Y, Ludwig M, van Wijk JA et al (2017) Proteinuria in dent disease: a review of the literature. Pediatr Nephrol 32(10):1851\u20131859. https:\/\/doi.org\/10.1007\/s00467-016-3499-x","journal-title":"Pediatr Nephrol"},{"key":"2054_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-981-13-8871-2_7","volume-title":"Renal fibrosis: mechanisms and therapies. Advances in experimental medicine and biology","author":"L Yang","year":"2019","unstructured":"Yang L (2019) How acute kidney injury contributes to renal fibrosis. In: Liu BC, Lan HY, Lv LL (eds) Renal fibrosis: mechanisms and therapies. Advances in experimental medicine and biology. Springer, Cham, pp 117\u2013142. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_7"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02054-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-02054-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02054-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:35Z","timestamp":1777564415000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/7\/1973\/8306335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["2054"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-02054-y","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M Betton, M Hureaux and A Blanchard declare no conflict of interest. P Houillier reports funding, consultancy and honoraria with Takeda Shire and consultancy with Kyowa-Kirin, outside of this study. R. Vargas-Poussou reports consultancy with Advicenne, outside of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors confirm that the study conforms to recognized standards of European Medicines Agency Guidelines for Good Clinical Practice and has been performed in accordance with the local ethical approvals committee of Assistance Publique\u2014H\u00f4pitaux de Paris and\u00a0conducted in accordance with the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 and 2008.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"Written consent for genetics analysis, publication of clinical information was obtained from all patients and legal representants, in accordance with French Bioethics Law of 2004.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}